Active Ingredient(s): Tinzaparin
FDA Approved: * July 14, 2000
Pharm Company: * PHARMION
Category: Blood Thinner (Anticoagulant)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Innohep Overview

Tinzaparin is an antithrombotic drug in the heparin group. It is a low molecular weight heparin (LMWH) marketed as Innohep worldwide. It has been approved by the U.S. Food and Drug Administration (FDA) for once daily treatment and prophylaxis of deep vein thrombosis and pulmonary embolism.[4] Tinzaparin sodium is the only low molecular weight heparin shown to be safe in pregnancy and in critically ill people with renal failure at both treatment and prophylaxis dose levels.[5] It can be given ...

Read more Innohep Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Innohep Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 20,000 iu/ml, 20000unit/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Innohep: (1 result)

Sorted by National Drug Code
  • 50222-342 Innohep 20000 [iu]/Ml Subcutaneous Injection, Solution by Leo Pharma Inc.

Other drugs which contain Tinzaparin or a similar ingredient: (1 result)